Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$1,145.03 USD
-5.16 (-0.45%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1,150.00 +4.97 (0.43%) 6:12 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $11.72 | -13.46% |
Earnings Summary
For their last quarter, Regeneron Pharmaceuticals (REGN) reported earnings of $11.56 per share, beating the Zacks Consensus Estimate of $10.57 per share. This reflects a positive earnings surprise of 9.37%. Look out for REGN's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of $11.72 per share, reflecting a year-over-year increase of 1.12%.
Earnings History
Price & Consensus
Zacks News for REGN
AZN Gets FDA Nod for Fasenra Label Expansion in Rare Disease
REGN: What are Zacks experts saying now?
Zacks Private Portfolio Services